A carregar...
Oligonucleotide therapeutics in neurodegenerative diseases
Therapeutics that directly target RNAs are promising for a broad spectrum of disorders, including the neurodegenerative diseases. This is exemplified by the FDA approval of Nusinersen, an antisense oligonucleotide (ASO) therapeutic for spinal muscular atrophy (SMA). RNA targeting therapeutics are cu...
Na minha lista:
| Publicado no: | RNA Biol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6152438/ https://ncbi.nlm.nih.gov/pubmed/29560813 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15476286.2018.1454812 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|